Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Acta Biomaterialia|December 29, 2025
Mitochondrial transfer through tunneling nanotubes inspires an innovative strategy for intercellular drug deliveryYitian Du, Yiwei Peng, Yiliang Yang, et al.Anesthesiology|August 15, 2012
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trialJean Wong, Amir Abrishami, Yiliang Yang, et al.Plos One|March 20, 2010
Interaction of E2 glycoprotein with heparan sulfate is crucial for cellular infection of Sindbis virusWuyang Zhu, Lihua Wang, Yiliang Yang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 9, 2020
A dual receptors-targeting and size-switchable "cluster bomb" co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancerYashi Wang, Sheng Yin, Lin Mei, et al.Nanoscale|May 13, 2025
Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapyZhengze Lu, Yang Long, Xingli Cun, et al.Drug Delivery|November 26, 2025
Targeted strategy by curcumin and tideglusib biomimetic nano-systems alleviates oxidative stress and inflammation under ischemic strokeJiajia Li, Yiliang Yang, Meng Lin, et al.Nanoscale|May 18, 2018
A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapyZhengze Lu, Yang Long, Xingli Cun, et al.Nature Communications|December 23, 2025
Leveraging engineered mitochondria through intercellular communication network for accelerated transport and deliveryYiwei Peng, Datong Gao, Yiliang Yang, et al.Biomaterials|April 19, 2024
Hierarchical self-recognition and response in CSC and non-CSC micro-niches for cancer therapyYiliang Yang, Yiwei Peng, Yitian Du, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 9, 2020
Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapyMan Li, Mengmeng Li, Yiliang Yang, et al.Pageof 3